Find Academic Supervisors

Esther MaasView profile

Assistant Professor

• Epidemiology
• Musculoskeletal Health
• Health Technology Assessment
• +3 more

Esther Maas is an Assistant Professor in Methodology and Biostatistics at the Department of Health Sciences, Vrije Universiteit Amsterdam. She is affiliated with the Amsterdam Movement Sciences (AMS) Research Institute as a member of the Musculoskeletal Health Program board. Her research focuses on epidemiological studies in musculoskeletal health, healthcare cost-effectiveness, and occupational health interventions, funded by organizations like WHO and ZonMW. Key projects include longitudinal physical activity trajectories in older adults, low back pain treatment guidelines, and cost analyses in musculoskeletal disorders. Teaching roles include coordination of epidemiology courses for Health Sciences students and supervision of bachelor’s internships. Her methodological expertise includes latent class growth models and sequence analyses. Recent work addresses post-COVID-19 work trajectories and cost-effectiveness of interventions like motivational interviewing in occupational settings. Research Interests: - Musculoskeletal Health Outcomes - Health Technology Assessment - Cost-effectiveness Analysis - Longitudinal Trajectory Modeling - Occupational Rehabilitation Notable Projects: - BACE-C cohort study on chiropractic care costs - MI-NAV economic evaluation of vocational advice interventions - Physiotherapists’ use of osteoarthritis outcome scores post-arthroplasty

Thijs ReyniersView profile

Researcher

• Sexual Health
• HIV Research
• PrEP Implementation
• +5 more

Thijs Reyniers is a researcher at the Institute of Tropical Medicine Antwerp, specializing in sexual health and HIV prevention research with a particular focus on PrEP (Pre-Exposure Prophylaxis) implementation. He holds dual PhDs in Social Health Sciences from Vrije Universiteit Brussel and Health Sciences from Ghent University, which he obtained in 2015 after completing his Master's degree in Sociology (Major: Sociology of Health) at Ghent University in 2009. His research expertise spans both quantitative and qualitative methodologies, with significant contributions to understanding sexual health behaviors, HIV prevention strategies, and healthcare service delivery for key populations including men who have sex with men, transgender individuals, and sex workers. Dr. Reyniers serves as the social science coordinator for the be-prep-ared study and leads multiple research projects examining PrEP implementation across different contexts, including Belgium and Burkina Faso. Sexual Health and HIV Research Group at Institute of Tropical Medicine Be-prep-ared study social science coordinator Principal investigator on multiple NIH/Flemish Government-funded projects Collaborator with international research teams across Europe and Africa His research interests focus on the intersection of social science and public health, particularly examining how social, behavioral, and structural factors influence the implementation and effectiveness of HIV prevention strategies. Dr. Reyniers' work emphasizes mixed-methods approaches to understand both the quantitative outcomes and qualitative experiences of PrEP users and healthcare providers. Analysis of his recent publications shows a strong trend toward implementation science research examining real-world PrEP delivery systems, with particular attention to user experiences, healthcare service preferences, and barriers to access among diverse populations. His work bridges clinical HIV prevention with social science perspectives to develop more responsive and effective sexual health services. Dr. Reyniers has secured multiple competitive research grants from the Research Fund - Flanders and Flemish Government agencies, supporting his work on PrEP implementation in Belgium and internationally. His projects often involve interdisciplinary collaborations with clinicians, epidemiologists, and community organizations to ensure research relevance and applicability. He has supervised research assistants and contributed to mentoring early-career researchers through his involvement in multiple PhD projects. His work has been recognized through publication in high-impact journals including The Lancet HIV and AIDS and Behavior, and has been featured in multiple news outlets and social media platforms.

Semih SevimView profile

Researcher

• Robotics
• Nanotechnology
• Biomedical Engineering
• +3 more

Dr. Semih Sevim is a Researcher in the Department of Robotics and Intelligent Systems at ETH Zürich. His work focuses on advanced robotics, nanotechnology, and their biomedical applications. He leads projects involving microrobotics, smart materials, and microfluidic manufacturing systems. His research integrates engineering principles with material science to develop innovative solutions for targeted therapies, regenerative medicine, and autonomous systems. Key research themes include magnetoelectric microrobots for spinal cord injury treatment, piezoelectric catalysis for biomedical applications, and microfluidic-based synthesis of advanced materials. He has pioneered techniques for on-the-fly material fabrication and wireless neural stimulation systems. Advising: Supervises doctoral student Roshan Shankar Kaundinya in robotics and materials engineering. His work bridges fundamental research with clinical applications, emphasizing translational technologies. Publications highlight advancements in microrobot design, biodegradable materials, and microfluidic systems, reflecting a multi-disciplinary approach to robotics and nanotechnology.

• Molecular Biology
• Biochemistry
• Nutrigenomics
• +7 more

Josep Mercader Barceló is a Full Professor in the Department of Fundamental Biology and Health Sciences at the University of the Balearic Islands (UIB), where he has been a faculty member since 2011. He is affiliated with the Faculty of Science and teaches in the Biochemistry and Molecular Biology programs. His academic roles include teaching core biochemistry courses and supervising Master’s and doctoral students in translational public health, global health, and personalized nutrition programs. Degree in Biochemistry, University of the Balearic Islands (2002) PhD in Biochemistry, University of the Balearic Islands (2008) His research focuses on the molecular basis of metabolic diseases such as obesity and diabetes, molecular interactions of nutrients and drugs, and translational applications in nutrigenomics and veterinary innovation. He integrates molecular biology with public and global health, particularly under the One Health framework. His recent work emphasizes innovation in diagnostics and therapeutics, including the development of the commercial nutrigenetic test Metigentiy. While no specific publications are listed, his research output is reflected in innovation projects and leadership in multiple R&D groups. He has secured recognition for three six-year research periods and three five-year teaching periods, indicating sustained academic productivity. Member, FI-TRACE Research Group (Flow Injection Analysis and Trace Analysis) Principal Investigator, MolONE Research Group (Molecular Biology, Health Geography, and One Health) Member, LiRCaP Research Group (Renal Lithiasis and Pathological Calcification) Member, WEPA Research Group (Mediterranean Parasitology and Ecoepidemiology) He has co-directed one doctoral thesis and six Master’s theses, and currently supervises three ongoing PhD candidates. He has been involved in industry-linked innovation projects with Stem Center SL and Alimentòmica SL, and in 2017 founded Foners Veterinary Clinic, where he serves as Scientific Director of Foners Medicina Veterinària i Innovació SL, focusing on developing novel veterinary treatments.

• Sleep Physiology
• Biological Rhythms
• Chronobiology
• +11 more

Silvia Tejada Gavela is a full-time Associate Professor in the Department of Biology at the University of the Balearic Islands (UIB), where she also serves as Deputy Director in Physiology. She is actively involved in teaching and research across multiple faculties, including Biology, Pharmacy, Physiotherapy, and Nutrition. Her academic and research profile is deeply interdisciplinary, spanning physiology, biochemistry, neuroscience, and environmental science. Education: Double degree in Biology and Biochemistry Ph.D. in Basic Medical Sciences, University of the Balearic Islands (UIB) Research Interests: Her primary research areas include sleep physiology, biological rhythms (chronobiology), linear and nonlinear analysis of time series, oxidative stress biomarkers and regulation, minimally invasive surgical techniques, growth plate studies, and aquatic ecotoxicology. She integrates physiological, biochemical, and ecological approaches in both animal and human health contexts. Publication Trends: Her recent scholarly work reflects a strong focus on oxidative stress in marine and clinical settings, neuropharmacology of wake states, surgical innovations, and the physiological and nutritional basis of health. The interdisciplinary nature of her research is evident in publications spanning neuroscience, orthopedics, toxicology, and nutrition. She has published 51 articles in international journals, with several in the first quartile. Scientific Contributions: Principal Investigator in the Neurofisiol R&D group Member of FI-TRACE and ECOINT research groups 67 oral/poster presentations at major scientific societies (SEBBM, SFRR, ERAS, EPOS, EFORT, SECF) Participant in 21 competitive research projects and 3 teaching innovation projects (PI in one each) Two research stays at prestigious institutions (Nijmegen, Tenerife) Advising and Grants: She is currently supervising doctoral theses in Nutrition, Neuroscience, Translational Public Health, and Plant Biology. She has led funded projects through National Plans, FIS, and CAIB special actions, including public administration research contracts. Her teaching spans undergraduate and master's levels in biology, physiotherapy, and nutrition. Laboratories and Research Teams: She leads the Neurofisiology (Neurofisiol) research group and is an active member of FI-TRACE (Flow Injection and Trace Analysis) and ECOINT (Interdisciplinary Ecology), fostering collaborative, multidisciplinary research in physiology, analytical biochemistry, and environmental health.

• Medical Genetics
• Ophthalmology
• Genomics
• +6 more

Professor Kathryn Burdon is Deputy Director of the Menzies Institute for Medical Research at the University of Tasmania. She holds a Professorial Research Fellowship and leads the Genetics and Cancer Theme. Her research focuses on identifying genetic factors underlying eye diseases such as glaucoma, cataracts, and keratoconus, with a particular emphasis on pediatric cases. She also investigates genetic contributions to multiple sclerosis and cardiovascular conditions. Education: PhD (2004) in pediatric cataract genetics from University of Tasmania; BSc(Hons) in albinism genetics (1999). Postdoctoral training at Wake Forest University. Research Interests Gene discovery for blinding eye diseases using whole genome sequencing and supercomputing analysis Role of genetic and environmental factors in treatment response (e.g., anti-VEGF therapy for macular degeneration) Utilization of the Tasmanian Ophthalmic Biobank and population records for genetic studies Development of zebrafish models to study disease mechanisms Article Trends Recent work focuses on pediatric cataract genetics, diabetic maculopathy GWAS, and polygenic risk scores for glaucoma. Emphasis on translating genetic findings into clinical care through predictive testing and personalized therapies. Awards Menzies Institute Academic Mentoring Award (2022) NHMRC Fellowships (Peter Doherty, Senior Research) Invited lectures at major ophthalmology and genetics conferences Grants & Supervision $2M+ in NHMRC and international grants for gene discovery projects Supervised over 20 PhD/Masters students on topics like EBV-MS links and pediatric cataract genetics Labs & Collaborations Leads the Tasmanian Ophthalmic Biobank and collaborates with global groups (Flinders University, Harvard, University of Melbourne) on multi-ethnic genetic studies.

Peter PopovView profile

Researcher

• Software Reliability
• System Dependability
• Software Fault-Tolerance
• +5 more

Peter Popov is a Reader at the Centre for Software Reliability (CSR) , City St George's, University of London , where he has been employed since 1997. He specializes in software dependability , fault tolerance , and stochastic modeling of critical infrastructures. Before his current position, he was an Associate Professor at the Bulgarian Academy of Sciences (1990-1997) and a Research Fellow at City St George's. Peter's academic journey began with a PhD in Computer Science from the Kiev National University of Technologies and Design (1989), following his BEng in Computer Engineering from the National Technical University of Ukraine (KPI, 1982). He has worked as a visiting scientist at renowned institutions including the Coordinated Science Laboratory at the University of Illinois at Urbana-Champaign , LAAS-CNRS in Toulouse, and Duke University . His research interests span Software reliability assessment System dependability Software fault-tolerance Performance evaluation Interdependencies of critical infrastructures He has contributed extensively to projects such as ReSIST , IRRIIS , DISPO , and AFTER , focusing on the dependability of composite systems and critical infrastructure resilience. Key publication trends reveal expertise in Stochastic modeling of autonomous vehicle safety Software diversity for fault tolerance Interdependency analysis in critical systems Bayesian reliability assessment Performance evaluation of distributed protocols Security implications in cyber-physical systems Peter has supervised several PhD students , including those researching autonomous vehicle resilience , safety assurance with ML components , and adaptable web services . His professional activities include serving on program committees for ISSRE , SAFECOMP , and EDCC conferences, as well as editorial contributions to CEUR Workshop Proceedings . He is proficient in Bulgarian , English , and Russian , with peer-review capabilities in all three languages.

Bridgette PeteetView profile

Professor

• Health disparities
• Substance misuse
• Mental health in minoritized populations
• +5 more

Bridgette Peteet is a Professor of Psychology at the School of Behavioral Health , Loma Linda University . Her work focuses on health disparities, substance misuse, and mental health in minoritized populations, particularly addressing prescription drug misuse, vaccine hesitancy, and sociocultural stressors. Her research spans community-academic partnerships and interventions, including Community-academic partnerships for vaccine equity Prescription drug misuse among women Racial identity and impostor phenomenon in African American students Her publications (15 most recent) cover topics like Post-COVID sequelae in minoritized youth (2025) Vaccine hesitancy in Black churches (2022) Substance use among biracial adults (2021) Longitudinal mental health impacts of childhood adversity (2021) Prescription drug trends in popular music (2021) HIV/HCV risk behaviors (2020) She has secured federal grants including HRSA Federal Graduate Psychology Education Programs (2023-2025) Primary Care Training and Enhancement (2022-2027) Primary Care Psychology Pipeline Program (2020-2025) Dr. Peteet serves on the Black Faculty and Staff Forum (Chair since 2021) APA Division 45 (Society for the Psychological Study of Ethnic Minority Issues; Secretary 2017-2020) Micah 6:8 NeighborGood Initiative (since 2020) Her Resilience and Disparities (RAD) Lab investigates psychological, behavioral, and cultural contexts contributing to health outcomes in minoritized populations.

Syed AliView profile

Associate Professor

• Virology
• Oncology
• Bioinformatics
• +7 more

Syed Ali is an Associate Professor in the Department of Biomedical Sciences at Nazarbayev University's School of Medicine. He joined Nazarbayev University in 2015 after previously working at The Aga Khan University across Pakistan, Kenya, and Afghanistan. His research focuses on viral evolution and drug screening against oncogenic viruses. PhD in Virology (1999) from Roswell Park Cancer Institute and State University of New York Post-doctoral training (1999-2003) at Harvard Medical School and Dana-Farber Cancer Institute Dr. Ali's research spans viral evolution and drug development against oncogenic viruses. His primary focus is on HIV, HPV, HCV, and HBV, with particular emphasis on immune evolution in high-risk populations across Pakistan, Afghanistan, Nepal, and Kenya. His laboratory has developed cell culture models and patented enzyme assays for testing antiviral drugs and vaccines. The research also employs bioinformatics tools to study viral transmission patterns and phylogeny in different populations. Analysis of Dr. Ali's publications reveals a strong focus on viral epidemiology in Central and South Asia, particularly studies of HIV transmission dynamics in high-risk groups including injection drug users, men who have sex with men, migrants, and refugees. His work combines molecular virology with epidemiological approaches to understand viral evolution and drug resistance patterns. Recent publications show increasing focus on Kazakhstan as a research location, particularly regarding HIV and HCV epidemiology in the post-Soviet context. Extensive research on HIV molecular epidemiology across multiple countries Studies on viral co-infections and drug resistance patterns Development of antiviral drug screening methods Investigation of viral epitope evolution in different populations Dr. Ali has supervised PhD and Master's students in Virology, Oncology, Bioinformatics, and Drug Design. His educational contributions include designing undergraduate and graduate courses in critical thinking, virology, oncology, and film criticism. He is recognized as an expert in e-learning and has developed massive open online courses (MOOCs) in Drug Discovery, making educational resources more accessible across resource-limited settings. His laboratory continues active research through multiple funded projects examining HIV transmission dynamics, drug resistance mutations, and viral evolution patterns in Kazakhstan and surrounding regions. Current projects include analysis of HIV-1 Pol epitopes, whole genome sequencing of Hepatitis C virus variants, and identification of emerging HIV infection hotspots using integrated phylodynamic-epidemiologic approaches.

Sophy ShihView profile

Research Fellow

• Health Economics
• Economic Evaluation
• Infectious Disease Control
• +4 more

Dr. Sophy Shih is a Senior Research Fellow and Health Economist at the Kirby Institute and the National Centre in HIV Epidemiology and Prevention (NPESU) at the Centre for Big Data Research in Health, University of New South Wales. With expertise in health economics and economic evaluation, she focuses on infectious disease control, particularly hepatitis C and HIV testing strategies and treatment uptake through point-of-care technology. Dr. Shih holds a BS, MPH, DrPH, and GradDipEco, reflecting her strong foundation in biomedical science, public health, and economics. Her educational background has equipped her to bridge clinical research with economic analysis to inform health policy decisions. Dr. Shih's research interests span health economics, economic evaluation, and health service research with a focus on infectious diseases. She specializes in designing and implementing trial-based economic assessments, performing economic evaluations, and building economic models. Her work has addressed viral infections, rare genetic diseases, cancers, diabetes, psycho-oncology, and disability prevention and screening. Currently, her research programs focus on scaling up point-of-care technology for HCV and HIV testing to enhance detection and reduce mortality and morbidity. Analysis of Dr. Shih's recent publications reveals a strong emphasis on cost-effectiveness analysis of hepatitis C and HIV testing strategies, particularly in high-risk populations. Her work frequently addresses implementation challenges in real-world settings, with a focus on prison populations, men who have sex with men, and people who inject drugs. She has made significant contributions to understanding how to optimize point-of-care testing strategies to achieve hepatitis C elimination goals. Elsevier Atlas 2023 award for the theme of United Nations Sustainable Development Goals (SDG 3): Good health and well-being, for her article "Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis" Dr. Shih actively supervises PhD candidates, including Huei Jiuan Wu (modeling HCV elimination among gay and bisexual men in Taiwan) and Quang Nguyen (cost-effectiveness of HIV viral load testing in PNG). She serves as a Chief Investigator on multiple major grants, including NHMRC Partnership Grants for hepatitis C elimination in prisons, MRFF grants for point-of-care testing scale-up, and CIHR Project Grants for decentralized testing implementation. Her collaborative approach involves working with multidisciplinary teams across Australia and internationally to address pressing public health challenges. As a member of the Kirby Institute's Social Epidemiology Research Program (SERP) and NPESU, Dr. Shih contributes to a vibrant research environment focused on evidence-based solutions for infectious disease control. Her work directly informs policy decisions regarding resource allocation for hepatitis C and HIV prevention and treatment programs.

Erik Olai PettersenView profile

Researcher

• Radiobiology
• Medical Physics
• Cancer Research
• +7 more

Erik Olai Pettersen is affiliated with the Department of Physics at the University of Oslo, focusing on radiobiology, cancer research, and hypoxia-driven mechanisms in tumors. He has supervised 38 master’s and 10 doctoral students. His work bridges laboratory research with clinical implications, particularly in radiation therapy and tumor microenvironment dynamics. Education & Employment: Civil Engineer (Biophysics) from NTH (Trondheim, 1972), Dr. philos (Radiobiology, University of Oslo, 1979). Long-term academic staff member with international research leadership roles in networks like METOXIA and OXNORM. Research Interests: Radiosensitivity modulation, hypoxia’s role in cancer therapy resistance, oxygen biology, and development of biosensors for in vitro studies. Key contributions include understanding hypoxia-induced metabolic shifts and optimizing radiation protocols using low-dose-rate strategies. Articles Overview: Recent work emphasizes photodynamic therapy monitoring, alginate-based cell culture systems, and hypoxia’s impact on mitochondrial function. His studies highlight translational applications in drug development and tumor metastasis prevention. Grants & Networks: Coordinated EU-funded projects (METOXIA, EUROXY) totaling over 20 partners. Focus areas include normoxia research, oxygen-sensing technologies, and drug candidate screening for hypoxic tumors. Labs & Teams: Collaborates with interdisciplinary teams in physics, oncology, and biomedical engineering, leveraging advanced biosensing and microfluidic platforms.

Peter ReherView profile

Professor

• Oral Surgery
• Implantology
• Oral and Maxillofacial Surgery
• +5 more

Professor Peter Reher is a German-Australian academic and specialist in Oral Surgery, affiliated with the University of Queensland's School of Dentistry and serving as Director of the Oral Health Alliance. He holds a Professorship in Oral Surgery and has held leadership roles, including Deputy Head of School and Clinical Director at Griffith University. His expertise spans oral surgery, implantology, trauma management, and craniofacial reconstruction. He completed his dentistry degree at PUC-Minas (Brazil), a Master’s in Oral & Maxillofacial Surgery, and a PhD at University College London's Eastman Dental Institute. His research focuses on dental implants, bone regeneration, temporomandibular disorders, and surgical techniques. He has authored textbooks on dental anatomy and published extensively in peer-reviewed journals. Awards include recognition from the Royal Society of Medicine and the International Journal of Oral & Maxillofacial Surgery. Education: Bachelor of Dentistry, PUC-Minas (1987) Master’s in Oral & Maxillofacial Surgery, Universidade Federal de Pelotas (1992) PhD in Oral & Maxillofacial Surgery, University College London Eastman Dental Institute (1999) Research interests include implantology, tissue engineering, craniofacial disorders, and surgical innovation. His articles address topics like dental implant outcomes, bone regeneration, and temporomandibular joint dysfunction. He has supervised numerous PhD/Master’s students and contributed to clinic accreditation standards in Australia. The Oral Health Alliance partnership between UQ and Metro North Health underscores his leadership in interdisciplinary oral health initiatives.

• Clinical Trials Methodology
• Biostatistics
• Health Economics
• +3 more

Professor Martyn Lewis is a Professor of Biostatistics at Keele University, with a career spanning over three decades in clinical trials methodology and musculoskeletal research. He holds a BSc in Mathematics and Biology, a PhD in Statistics, and an MSc in Health Economics. His academic journey includes roles at the School of Postgraduate Medicine and the Arthritis Research UK Primary Care Centre before his current position. His research focuses on clinical trials design, statistical and economic evaluations, and musculoskeletal pain management. He has led or contributed to 28 national grants totaling £28 million and published 161 peer-reviewed articles. Notable contributions include pioneering stratified care models for musculoskeletal pain (STarT MSK and STarT Back tools) and cost-effectiveness analyses of healthcare interventions. Prof. Lewis has supervised seven PhD students and one MSc student, examining four postgraduate degrees. He actively participates in research committees, including those overseeing trial oversight, grant funding, and teaching. His work emphasizes translating statistical rigor into practical healthcare solutions, particularly in primary care settings. Key achievements include the SCOPiC and STarT MSK trials, evaluating sciatica and musculoskeletal pain stratification, and the ENHANCE pilot trial integrating care for osteoarthritis and mental health. His awards include Fellowship of the Royal Statistical Society.

• Epidemiology
• Primary Care Medicine
• Musculoskeletal Medicine
• +3 more

Claire Burton is an NIHR Clinical Lecturer and Clinical Fellow in Primary Care at the School of Medicine, Keele University. She holds a PhD in musculoskeletal epidemiology (awarded 2020) and maintains a clinical role as a salaried GP at Silverdale & Ryecroft Practice in North Staffordshire. Her research focuses on musculoskeletal disorders, including carpal tunnel syndrome and frozen shoulder, with an emphasis on epidemiology, prognosis, and primary care management. She has led studies on pandemic impacts on musculoskeletal care, long-term outcomes of pediatric COVID-19, and the epidemiological links between diabetes and frozen shoulder. Dr. Burton’s educational background includes an MBChB from the University of Manchester/Keele University (2005), an MMedSci in Medical Science from Keele (via West Midlands Deanery funding), and doctoral studies supported by NIHR and SPCR fellowships. She is a member of the West Midlands RfPB Committee and the School’s Student Ethics Committee. Her research portfolio includes NIHR-funded studies on musculoskeletal epidemiology and pandemic healthcare adaptations. She has contributed to randomized trials like INSTINCTS (versus Arthritis-funded) and PANDA-S (PGfAR-funded), exploring interventions for musculoskeletal conditions. Her work bridges clinical practice and academic research, emphasizing patient-centered outcomes and healthcare system resilience. Dr. Burton teaches medical students and foundation trainees, supervising a Versus Arthritis-funded doctoral student analyzing frozen shoulder prognosis using CPRD data. Her grants include NIHR Clinical Lectureship support and funding from FOREUM and SPCR for pandemic-related studies.

• Routinely collected healthcare data
• Electronic Healthcare Records
• Large databases of EHRs
• +6 more

Dr. Agnieszka Lemanska is a Senior Lecturer in Health Data Science at the University of Surrey's School of Health Sciences within the Faculty of Health and Medical Sciences. She holds a joint appointment as a Senior Scientist at the National Physical Laboratory's Department of Data Science, where she contributes to improving healthcare data quality. Her research focuses on cancer-related studies using routinely collected healthcare data, with particular emphasis on early diagnosis and post-treatment outcomes. Dr. Lemanska earned her MSc in Pharmacy from the Medical University of Warsaw in 2005 and completed her PhD in Statistics and Machine Learning at the University of Bristol with GlaxoSmithKline funding. Her educational background bridges clinical pharmacy and advanced data science, creating a unique interdisciplinary perspective for her research. Her primary research interests center on routinely collected healthcare data, electronic healthcare records (EHRs), cancer-related primary care research, and data-driven early cancer diagnosis. She specializes in analyzing large databases of patient records including CPRD, ORCHID, and OpenSAFELY, with particular focus on pancreatic and prostate cancers. Her work addresses critical healthcare challenges including cancer diagnosis delays, treatment side effects, and healthcare system disruptions during the pandemic. Analysis of her recent publications reveals a strong focus on cancer epidemiology using large-scale electronic health records, with significant contributions to understanding pandemic impacts on cancer care. Her work demonstrates consistent methodological rigor across observational studies, systematic reviews, and clinical audits, with particular attention to real-world data applications in improving cancer diagnosis and treatment pathways. Dr. Lemanska actively contributes to multiple significant research projects including NPL Explorer's award for validating pancreatic cancer prediction algorithms, MRC Fellowship research on pandemic effects on cancer care, and EPSRC-funded PhD studentships investigating primary care data for early pancreatic cancer diagnosis. She has led important national audits on pancreatic enzyme prescribing and prostate cancer diagnosis disruptions during the pandemic. As an educator, she provides PhD, MSc, and BSc supervision while teaching across various healthcare programs including pharmacy, nursing, and physician associate curricula. Her international engagement includes serving as International Lead and Erasmus Coordinator for the School of Health Sciences, facilitating global academic collaborations and student exchanges.